Casey Gordon

Head of Private Investments

Casey joined TCP in 2006 as Head of Private Investments with responsibility for the firm’s private equity, venture capital, and real-estate investment programs and new business development. Since 2016, Casey has taken a leading role with Northgate Capital,  one of TCP’s strategic business interests, serving on the firm’s operating committee and being actively involved in the day-to-day management of the firm. Since 2018, Casey has been the Managing Partner of Northgate, providing oversight to Northgate’s venture capital and private equity investment programs, actively involved in client relationship development, and managing the firm’s strategic initiatives.

Casey brings over 16 years of experience sourcing and executing investments in private equity, real-estate, venture capital, and healthcare to TCP and Northgate. Casey currently serves on the Board of Directors for Atia Vision, Supira Medical, and Cerestra Advisors Private Limited. Casey served on the Board of Directors for NuVera Medical until it was sold to Ethicon, Inc., a wholly-owned subsidiary of Johnson & Johnson, in December 2020.

Casey holds a BA in Sociology from Johns Hopkins University and an MBA from the MIT Sloan School of Management